_Spatial_Biology.jpg)
The Artificial Intelligence-powered (AI) Spatial Biology Market Size is predicted to reach an 17.2 % CAGR during the forecast period for 2023-2031.
Machine learning algorithms, a subset of artificial intelligence (AI), have the capacity to analyze "big"-sized complex data in a decisive manner. As a result, it appears to be the most helpful instrument for analyzing and comprehending multi-omics data for patient-specific observations. AI-based technology specializes in both rapidly and precisely associating the qualities found in various types of data. The usefulness of using AI is in improving the speed and accuracy of exact diagnosis and, consequently, clinical decision-making. Researchers have identified subtypes within several cancer types using AI and the crucial underlying genes, proteins, RNAs, and miRNAs that could potentially serve as therapeutic targets. Additionally correlated with biological processes are these essential indicators.
The rapidly increasing data-based AI, technological improvements in deep learning, and the growing demand for cost control and operational efficiencies in drug discovery are significantly driving market expansion. Furthermore, the rising need for treatments to treat complicated disorders such as cancer is propelling the market forward. Adopting AI can potentially reduce the extensive progress required in drug discovery and clinical diagnostics research. For instance, Rebus Biosystems Inc recently announced a collaboration with Rosalind, Inc. to co-develop new spatial omics software. The technology will democratize data from Rebus EsperTM system single-cell spatial studies, making critical spatial omics insights available to the broader scientific community.
Market Segmentation:
The Artificial Intelligence-powered (AI) Spatial Biology Market is segmented on the data analysed, and applications. Based on data analysed, the market is segmented as DNA, RNA, and Protein. Based on Applications, the market is segmented as Translation Research, Drug Discovery and Development, Single Cell Analysis, Cell Biology, Clinical Diagnostics, and Other Applications.
In the region, the North America Artificial Intelligence-powered (AI) Spatial Biology Market holds a significant revenue share
North America dominated the market in 2021. Breakthroughs in technology, the presence of mature research infrastructure and influential companies, and rising investments in drug discovery R&D have all contributed to the growth of the regional market. North America is likely to be the leading market for artificial intelligence applications in spatial omics, driven by the region's substantial and expanding demand from research and the pharmaceutical industry. It is challenging and time-consuming to extract, analyse, and interpret biological information from images, even though new high-complexity spatial imaging approaches are now available.
Competitive Landscape:
Some major key players in the Artificial Intelligence-powered (AI) Spatial Biology Market:
- Nucleai, Inc.,
- Reveal Biosciences, Inc.,
- Alpenglow Biosciences,
- SpIntellx, Inc.,
- ONCOHOST,
- ai,
- Phenomic AI,
- BioTuring Inc.,
- Indica Labs,
- Rebus Biosystems, Inc.,
- Genoskin,
- Algorithmic Biologics,
- Castle Biosciences, Inc. (TissueCypher)
Artificial Intelligence-powered (AI) Spatial Biology Market Report Scope:
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 17.2 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
Data Analyzed, Application |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Nucleai, Inc., Reveal Biosciences, Inc., Alpenglow Biosciences, SpIntellx, Inc., ONCOHOST, Pathr.ai, Phenomic AI, BioTuring Inc., Indica Labs, Rebus Biosystems, Inc., Genoskin, Algorithmic Biologics, Castle Biosciences, Inc. (TissueCypher), and Other Prominent Players. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
